Cognos Therapeutics is a medical technology company focused on developing unique, radically advanced devices for the treatment of neurological diseases including brain and spinal cancers, and ...

In a move rumored for months, Big Blue to pay $5 billion in cash for the business intelligence company to fill out its information management portfolio. Martin LaMonica is a senior writer covering ...

eSpeaks’ Corey Noles talks with Rob Israch, President of Tipalti, about what it means to lead with Global-First Finance and how companies can build scalable, compliant operations in an increasingly ...

Users consuming data from enterprise resources use Cognos as their primary reporting tool for operational data. The courses listed below are based on user roles and licensing. Please review the roles ...

eSpeaks’ Corey Noles talks with Rob Israch, President of Tipalti, about what it means to lead with Global-First Finance and how companies can build scalable, compliant operations in an increasingly ...

INGLEWOOD, CA, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Cognos Therapeutics (“Cognos” and “the Company”), a leading innovator in medical technology, today proudly announced the formation of its Industry ...

Users consuming data from enterprise resources use Cognos as their main reporting tool for operational data. These videos are designed as both training tools, report training, and reference guides for ...

Business intelligence software maker Cognos Inc. Thursday announced it has agreed to acquire privately held Adaytum Inc. Adaytum, based in Minneapolis, makes collaboration software designed for ...

The following Cognos system reports (login required) are recommended by Accounting Services for Research and Sponsored Programs (ASRSP) for administrators to use when monitoring their unit's sponsored ...